Exact Sciences Corporation
US ˙ NasdaqCM ˙ US30063P1057
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityEXAS / Exact Sciences Corporation
InstitutionKBC Group NV
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
KBC Group NV closes position in EXAS / Exact Sciences Corporation

On May 7, 2026 - KBC Group NV filed a 13F-HR form disclosing ownership of 0 shares of Exact Sciences Corporation (US:EXAS) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 9,155 shares of Exact Sciences Corporation. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F EXACT SCIENCES COM 30063P105 0 -100.00 0
2026-01-26 2025-12-31 13F EXACT SCIENCES COM 30063P105 9,155 -4,367 -32.30 1 0.0021
2026-01-20 2025-09-30 13F EXACT SCIENCES COM 30063P105 13,522 -295 -2.14 1 0.0018
2025-08-08 2025-06-30 13F EXACT SCIENCES COM 30063P105 13,817 -13,925 -50.19 1 -100.00 0.0020
2025-04-25 2025-03-31 13F EXACT SCIENCES COM 30063P105 27,742 0 0.00 1 0.00 0.0037
2025-01-22 2024-12-31 13F EXACT SCIENCES COM 30063P105 27,742 490 1.80 2 0.00 0.0043
2024-11-06 2024-09-30 13F EXACT SCIENCES COM 30063P105 27,252 5,368 24.53 2 0.0056
2024-07-17 2024-06-30 13F EXACT SCIENCES COM 30063P105 21,884 0 0.00 1 -100.00 0.0028
2024-05-08 2024-03-31 13F EXACT SCIENCES COM 30063P105 21,884 0 0.00 2 0.00 0.0048
2024-02-13 2023-12-31 13F EXACT SCIENCES COM 30063P105 21,884 -21,199 -49.21 2 -50.00 0.0057
2024-02-15 2023-09-30 13F/A-1 EXACT SCIENCES COM 30063P105 43,083 5,950 16.02 3 -33.33 0.0120
2023-11-22 2023-09-30 13F EXACT SCIENCES COM 30063P105 36,885 0 3 0.0144
2024-02-15 2023-06-30 13F/A-1 EXACT SCIENCES COM 30063P105 37,133 -63,979 -63.28 3 -50.00 0.0143
2023-07-28 2023-06-30 13F EXACT SCIENCES COM 30063P105 36,885 -63,979 3 0.0144
2024-02-14 2023-03-31 13F/A-1 EXACT SCIENCES COM 30063P105 101,112 49,494 95.89 7 200.00 0.0291
2023-05-04 2023-03-31 13F EXACT SCIENCES COM 30063P105 100,864 -115,524 7 0.0322
2024-02-14 2022-12-31 13F/A-1 EXACT SCIENCES COM 30063P105 51,618 -165,160 -76.19 3 -71.43 0.0124
2023-02-13 2022-12-31 13F EXACT SCIENCES COM 30063P105 216,388 -390 7 0.0000
2024-02-15 2022-09-30 13F/A-1 EXACT SCIENCES COM 30063P105 216,778 -25,668 -10.59 7 -22.22 0.0366
2022-11-08 2022-09-30 13F EXACT SCIENCES COM 30063P105 216,388 -26,058 7,030 0.0367
2024-02-14 2022-06-30 13F/A-1 EXACT SCIENCES COM 30063P105 242,446 -332,884 -57.86 10 -77.50 0.0476
2022-07-26 2022-06-30 13F EXACT SCIENCES COM 30063P105 241,120 -334,210 9,498 0.0478
2024-02-14 2022-03-31 13F/A-1 EXACT SCIENCES COM 30063P105 575,330 83,122 16.89 40 5.26 0.1590
2022-05-06 2022-03-31 13F EXACT SCIENCES COM 30063P105 575,330 83,122 40,227 0.1485
2024-02-14 2021-12-31 13F/A-1 EXACT SCIENCES COM 30063P105 492,208 315,078 177.88 38 -99.78 0.1264
2022-02-03 2021-12-31 13F EXACT SCIENCES COM 30063P105 492,208 315,078 38,309 0.1200
2021-11-10 2021-09-30 13F EXACT SCIENCES COM 30063P105 177,130 148,100 510.16 16,907 368.47 0.0620
2022-02-15 2021-06-30 13F/A-1 EXACT SCIENCES COM 30063P105 29,030 -2,877 -9.02 3,609 -14.17 0.0130
2021-08-11 2021-06-30 13F EXACT SCIENCES COM 30063P105 29,030 -2,877 3,609 0.0130
2022-02-14 2021-03-31 13F/A-1 EXACT SCIENCES COM 30063P105 31,907 12,744 66.50 4,205 -83.44 0.0170
2021-04-26 2021-03-31 13F EXACT SCIENCES COM 30063P105 31,907 12,744 4,205 0.0170
2022-02-14 2020-12-31 13F/A-1 EXACT SCIENCES COM 30063P105 19,163 6,162 47.40 25,389 1,816.15 0.0119
2021-02-10 2020-12-31 13F EXACT SCIENCES COM 30063P105 19,163 6,162 2,539 0.0117
2022-02-14 2020-09-30 13F/A-1 EXACT SCIENCES COM 30063P105 13,001 -6,210 -32.33 1,325 -20.66 0.0078
2020-10-28 2020-09-30 13F EXACT SCIENCES COM 30063P105 13,001 -6,210 1,325 0.0078
2022-02-14 2020-06-30 13F/A-1 EXACT SCIENCES COM 30063P105 19,211 -819 -4.09 1,670 43.72 0.0110
2020-08-10 2020-06-30 13F EXACT SCIENCES COM 30063P105 19,211 -819 1,670 0.0112
2020-05-04 2020-03-31 13F EXACT SCIENCES COM 30063P105 20,030 7,116 55.10 1,162 -2.68 0.0097
2020-02-11 2019-12-31 13F EXACT SCIENCES COM 30063P105 12,914 12,914 1,194 0.0075
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.